These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 11195438)
21. Does fundoplication change the risk of esophageal cancer in the setting of GERD? Shaheen NJ Am J Gastroenterol; 2005 May; 100(5):1009-11. PubMed ID: 15842571 [TBL] [Abstract][Full Text] [Related]
22. Barrett's oesophagus, cancer and antireflux surgery. Watson DI ANZ J Surg; 2014; 84(7-8):508-9. PubMed ID: 25065429 [No Abstract] [Full Text] [Related]
27. Epidemiology of esophageal adenocarcinoma. Pera M; Manterola C; Vidal O; Grande L J Surg Oncol; 2005 Dec; 92(3):151-9. PubMed ID: 16299786 [TBL] [Abstract][Full Text] [Related]
28. Antireflux surgery and Barrett's esophagus regression: wheel of fortune, or to tell the truth? Sampliner R Am J Gastroenterol; 1991 May; 86(5):645-6. PubMed ID: 2028963 [No Abstract] [Full Text] [Related]
29. The relationship between gastroesophageal reflux, intestinal metaplasia and adenocarcinoma of the esophagus. Stein HJ; Feith M; Feussner H Langenbecks Arch Surg; 2000 Aug; 385(5):309-16. PubMed ID: 11026701 [TBL] [Abstract][Full Text] [Related]
30. [Barrett's esophagus can progress to adenocarcinoma following total duodenal diversion]. Villar F; Scotté M; Songné B; Cardot F; Sauvanet A; Michot F; Ténière P Gastroenterol Clin Biol; 2002 Feb; 26(2):183-4. PubMed ID: 11938074 [No Abstract] [Full Text] [Related]
31. Barrett's oesophagus--are British gastroenterologists denying their patients prevention of malignant change? Rosin RD J R Coll Surg Edinb; 2002 Jun; 47(3):521-2. PubMed ID: 12109604 [TBL] [Abstract][Full Text] [Related]
32. Anti-reflux surgery is superior to medical management in patients with Barrett's esophagus with low-grade dysplasia. Chandrasoma P Am J Gastroenterol; 2007 Sep; 102(9):2111-2. PubMed ID: 17727447 [No Abstract] [Full Text] [Related]
33. Risk factors for esophageal adenocarcinoma after antireflux surgery. Löfdahl HE; Lu Y; Lagergren P; Lagergren J Ann Surg; 2013 Apr; 257(4):579-82. PubMed ID: 23426349 [TBL] [Abstract][Full Text] [Related]
35. Barrett's Esophagus and the Prevention of Esophageal Adenocarcinoma. Lightdale CJ Gastrointest Endosc Clin N Am; 2017 Jul; 27(3):xiii-xiv. PubMed ID: 28577774 [No Abstract] [Full Text] [Related]
36. Management of Barrett's esophagus: cases and questions. Bresalier R Semin Oncol; 2005 Dec; 32(6 Suppl 9):S2-5. PubMed ID: 16399421 [TBL] [Abstract][Full Text] [Related]
37. Risk factors for esophageal cancer development. Falk GW Surg Oncol Clin N Am; 2009 Jul; 18(3):469-85. PubMed ID: 19500737 [TBL] [Abstract][Full Text] [Related]
38. Barrett's-related esophageal adenocarcinoma: is chemoprevention a potential option? Fennerty MB; Triadafilopoulos G Am J Gastroenterol; 2001 Aug; 96(8):2302-5. PubMed ID: 11513166 [TBL] [Abstract][Full Text] [Related]
39. The value of surveillance and other unresolved issues in the management of Barrett's esophagus. Playford RJ Nat Clin Pract Gastroenterol Hepatol; 2005 Feb; 2(2):60-1. PubMed ID: 16265103 [No Abstract] [Full Text] [Related]